3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
1
Interventions
bosutinib
2
Imatinib Mesylate
2
nilotinib
1
asciminib
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Philadelphia Chromosome
×
ponatinib
×
Clear all
No trials found.